Thyrocare Technologies Limited — Results, 03-02-2025: Integrated Filing- Financial

Thyrocare has announced a board meeting to discuss the limited review report on the consolidated financial results for the quarter and nine months ended December 31, 2024. A clerical error caused the omission of a page in the initial report submitted. This has been corrected without any impact on the reported financial figures. The revision confirms the company's financial results remain unchanged. The acquisition of Vimta Labs' diagnostic services, finalized in October 2024, may enhance operational capacity. Investors may view this update positively, considering the transparency in rectifying the error and the strategic acquisitions contributing to future growth.